Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells

International Journal of Molecular Medicine

Volumn 22, Issue 5, 2008, Pages 613-618

  Su, Chin Cheng ^a,b,d   Chen, Guang Wei ^c,d   Lin, Jaung Geng ^d  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Bax; Caspase 3; Colo 205; p21; Tanshinone I

Indexed keywords

CASPASE 3; PROTEIN BAX; PROTEIN P21; PROTEIN P53; TANSHINONE I; TRYPAN BLUE; ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; PHENANTHRENE DERIVATIVE; TANSHINONE; TP53 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRAIN COLO 205; CELL VIABILITY; COLON CANCER; CYTOTOXICITY; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; WESTERN BLOTTING; BIOSYNTHESIS; CHEMISTRY; COLON TUMOR; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; SALVIA MILTIORRHIZA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; G0 PHASE; G1 PHASE; HUMANS; PHENANTHRENES; SALVIA MILTIORRHIZA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 59149096511     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000063     Document Type: Article

References (21)

1. Martikainen P, Kyprianou N, Tucker RW and Isaacs JT: Programmed death of non-proliferating and androgen-independent prostatic cancer cells. Cancer Res 51: 4693-4701, 1991.
2. Kyprianou N, Bains A and Jacobs S: Induction of apoptosis in androgen-independent human prostatic cancer cells undergoing thymineless death. Prostate 25: 66-75, 1994.
3. Lotan R: Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J Natl Cancer Inst 87: 1655-1657, 1995.
4. Kaufman SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870-5878, 1989.
5. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME and Huang Y: Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7: 563-568, 1993.
6. Li ZT, Yang BJ and Ma GE: Chemical studies of Salvia miltiorrhiza f. alba. Yaoxue Xuebao 26: 209-213, 1991.
7. Lin TJ: Antioxidation mechanism of schizandrin and tanshinonatic acid A and their effects on the protection of cardio toxic action of adriamycin. Shengli Kexue Jinzhan 22: 342-345, 1991.
8. Wu WL, Chang WL and Chen CF: Cytotoxic activities of tanshinone against human carcinoma cell lines. Am J Chin Med 19: 207-216, 1991.
9. Liang Y, Yang YM and Yuan SL: Studies on Pharmic mechanism and clinic application of Tanshinone. Tradit Herb Drugs 31: 304-306, 2000.
10. Sung HJ, Choi SM, Yoon Y and An KS: Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3. Exp Mol Med 31: 174-178, 1999.
11. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF and Zhang J: Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol 10: 2024-2028, 2004.
12. Yuan S, Wang Y, Chen X, Song Y and Yang Y: A study on apoptosis of nasopharyngeal carcinoma cell line induced by Tanshinone II A and its molecular mechanism. Huaxi Yike Daxue Xuebao 33: 84-86,2002.
13. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J and Wang W: Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 116: 799-807, 2005.
14. Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC and Chung JG: Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 25: 971-979, 2005.
15. Bradford MM: A rapid and sensitive method for the quantization of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
16. Chen HC, Hsieh WT, Chang WC and Chung JG: Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 42: 1251-1257, 2004.
17. El-Deiry WS, TokinoT, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
18. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684, 1995.
19. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
20. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
21. Zheng G-C and Li Z-Y: Study on the anti-tumor effect and mechanism of tanshinone I. J Pract Oncol 20: 33-35, 2005.